Collaboration Agreement with AbbVie (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Jan. 31, 2023	Mar. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Collaboration revenue		$ 2,364
Deferred revenue		27,636
Collaboration agreement with AbbVie
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Non refundable upfront payment	$ 30,000
Anniversary of first commercial sale (in years)	10 years
Performance obligation	$ 30,000
Collaboration revenue		2,400
Deferred revenue		$ 27,600
Estimated research and development period		1 year 6 months
Collaboration agreement with AbbVie | Maximum
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Additional platform access payments	70,000
Development and commercial sale milestone receivable per target	120,000
Sales based milestone based on achievement	$ 150,000